Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Authors
Keywords
-
Journal
EYE
Volume 27, Issue 12, Pages 1339-1346
Publisher
Springer Nature
Online
2013-11-08
DOI
10.1038/eye.2013.236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections
- (2013) Sanjay Sharma et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
- (2012) Francesco Semeraro et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- The Efficacy of Intravitreal Bevacizumab for Acute Central Serous Chorioretinopathy
- (2012) Erdinc Aydin JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Review and update of central serous chorioretinopathy
- (2011) Alexander Ross et al. CURRENT OPINION IN OPHTHALMOLOGY
- Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy
- (2011) M J Koss et al. EYE
- The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab
- (2011) Shelly T. Lee et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
- (2011) Farzin Forooghian et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy
- (2010) Joo Yong Lee et al. ACTA OPHTHALMOLOGICA
- Association Between the Efficacy of Photodynamic Therapy and Indocyanine Green Angiography Findings for Central Serous Chorioretinopathy
- (2010) Ryo Inoue et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study
- (2010) Ozgur Artunay et al. CURRENT EYE RESEARCH
- Central serous chorioretinopathy: an update on pathogenesis and treatment
- (2010) M Gemenetzi et al. EYE
- The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy
- (2010) Ji Won Lim et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Results of One-Year Follow-Up Examinations after Intravitreal Bevacizumab Administration for Chronic Central Serous Chorioretinopathy
- (2010) Maiko Inoue et al. OPHTHALMOLOGICA
- AQUEOUS HUMOR AND PLASMA LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY
- (2010) Ji Won Lim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL BEVACIZUMAB INJECTION FOR CENTRAL SEROUS CHORIORETINOPATHY
- (2010) SU JIN LIM et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect
- (2009) Hyun Kyung Seong et al. OPHTHALMOLOGICA
- Randomized Trial of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Macular Photocoagulation in Diabetic Macular Edema
- (2009) Masoud Soheilian et al. OPHTHALMOLOGY
- Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema
- (2008) Xiaoyun Fang et al. ACTA OPHTHALMOLOGICA
- A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports)
- (2008) Mitzy E. Torres-Soriano et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Central serous chorioretinopathy
- (2007) Maria Wang et al. ACTA OPHTHALMOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More